Profound Medical Corp. (PROF) shareholders
Close on Nov 12, 2026Market cap $271.80MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Neil Gagnon Joint filing with Gagnon Securities LLC (6.40%) | 3,346,743 | 11.20% | 13G (passive) amendment | Dec 31, 2024 |
| FIL Limited Joint filing with Pandanus Partners, L.P. (5.62%), Pandanus Associates, Inc. (5.62%) | 1,200,635 | 5.62% | 13G (passive) amendment | Feb 9, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PROF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FIL Ltd | 2,370,000 | 6.49% | $15.76M | +30,000 | 0.01% |
| Gagnon Securities LLC | 1,960,074 | 5.37% | $13.03M | +15,750 | 2.51% |
| Royce & Associates LP | 1,199,564 | 3.28% | $7.98M | +83,216 | 0.06% |
| Timelo Investment Management Inc. | 1,114,967 | 3.05% | $7.41M | – | 2.13% |
| Gagnon Advisors, LLC | 962,186 | 2.63% | $6.40M | – | 4.07% |
| Letko, Brosseau & Associates Inc | 935,725 | 2.56% | $5.40M | −17,450 | 0.08% |
| First Eagle Investment Management, LLC | 880,414 | 2.41% | $5.85M | +557,707 | 0.00% |
| Rosalind Advisors, Inc. | 828,118 | 2.27% | $5.51M | – | 2.05% |
| Z3 Capital Partners, LLC | 820,941 | 2.25% | $5.46M | +2,950 | 1.15% |
| MMCAP International Inc. SPC | 671,356 | 1.84% | $4.46M | −73,796 | 0.38% |
| Ardsley Advisory Partners LP | 575,000 | 1.57% | $3.82M | – | 0.40% |
| Ring Mountain Capital, LLC | 511,917 | 1.40% | $3.40M | +812 | 1428.53% |
| Lagoda Investment Management, L.P. | 501,325 | 1.37% | $3.33M | +60,310 | 1.83% |
| Royal Bank of Canada | 491,495 | 1.35% | $3.27M | −1,565 | 0.00% |
| DAFNA Capital Management LLC | 260,360 | 0.71% | $1.73M | −2,645 | 0.33% |
| Bleichroeder LP | 254,753 | 0.70% | $1.69M | – | 0.30% |
| Formula Growth Ltd | 240,088 | 0.66% | $1.60M | −1,050 | 0.56% |
| National Bank Of Canada /Fi/ | 218,698 | 0.60% | $1.25M | +1,523 | 0.00% |
| Thompson Davis & Co., Inc. | 216,535 | 0.59% | $1.44M | +750 | 0.86% |
| Dauntless Investment Group, LLC | 208,369 | 0.57% | $1.39M | −32,370 | 1.09% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 16M | 45.2% | 5 / 13 | 17 / 5 | 1M | 0M |
| Q1 2026 | 57 | 16M | 44.7% | 10 / 21 | 7 / 16 | 2M | 2M |
| Q4 2025 | 63 | 16M | 44.0% | 26 / 18 | 7 / 6 | 5M | 0M |
| Q3 2025 | 43 | 11M | 30.3% | 5 / 10 | 11 / 6 | 0M | 2M |
| Q2 2025 | 44 | 13M | 35.4% | 4 / 16 | 12 / 9 | 1M | 1M |
| Q1 2025 | 49 | 13M | 35.1% | 7 / 13 | 11 / 10 | 0M | 1M |
| Q4 2024 | 52 | 14M | 37.7% | 17 / 19 | 5 / 6 | 5M | 0M |
| Q3 2024 | 44 | 9M | 25.8% | 9 / 12 | 8 / 4 | 1M | 1M |
| Q2 2024 | 39 | 10M | 26.1% | 4 / 13 | 9 / 7 | 0M | 0M |
| Q1 2024 | 42 | 10M | 26.1% | 5 / 12 | 13 / 8 | 1M | 0M |
| Q4 2023 | 45 | 9M | 25.3% | 16 / 10 | 9 / 2 | 2M | 0M |
| Q3 2023 | 31 | 7M | 20.5% | 1 / 9 | 8 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
8 funds held PROF in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of PROF | Value | % of fund | As of |
|---|---|---|---|---|---|
| First Eagle Small Cap Opportunity Fund | 398,048 | 1.09% | $2.94M | 0.10% | Jul 31, 2026 |
| Royce Micro-Cap Fund | 343,903 | 0.94% | $1.61M | 0.53% | Jun 30, 2026 |
| Royce Capital Fund - Micro-Cap Portfolio | 112,878 | 0.31% | $529.19K | 0.53% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 22,878 | 0.06% | $155.80K | 0.00% | May 31, 2026 |
| The Canadian Small Company Series | 4,590 | 0.01% | $33.87K | 0.00% | Jul 31, 2026 |
| International Core Equity 2 Portfolio | 3,806 | 0.01% | $28.09K | 0.00% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 1,891 | 0.01% | $13.96K | 0.00% | Jul 31, 2026 |
| Dimensional International Small Cap ETF | 908 | 0.00% | $4.79K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Arun Swarup Menawat | CEO, Director | 587,089 | 1.61% | May 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Arun Swarup Menawat CEO, Director | May 16, 2025 | Buy | +12,027 | $4.73 | $56.89K | 587,089 |
| Arun Swarup Menawat CEO, Director | May 15, 2025 | Buy | +10,003 | $4.33 | $43.31K | 575,062 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Profound Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 25,283 shares on Sep 28, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Goodman Abbey Officer | Nov 12, 2024 | 13,014 | $105.54K | Nov 12, 2024 | RSU Vesting |
| Jordan-Cornet Helen Spouse | Sep 23, 2024 | 564 | $4.22K | Sep 18, 2024 | Open Market Purchase |
| Jordan-Cornet Helen Spouse | Sep 23, 2024 | 631 | $4.73K | Sep 23, 2024 | Open Market Purchase |
| Jordan-Cornet Helen Member of immediate family of any of the foregoing | Aug 30, 2024 | 22 | $219 | Aug 30, 2024 | OPEN MARKET PURCHASE |
| Jordan-Cornet Helen Member of immediate family of any of the foregoing | Aug 27, 2024 | 105 | $1.05K | Aug 27, 2024 | Open Market Purchase |
| Goodman Abbey Officer | Mar 26, 2024 | 8,692 | $70.06K | Mar 26, 2024 | Vested Restricted Stock Units |
See a number that looks wrong?